Floatz logo

PREDNISONE TABLETS

Previously Treated Childhood Rhabdomyosarcoma

Children's Oncology GroupSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Previously Treated Childhood Rhabdomyosarcoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Eisai Inc.
Phase 2BBB
CALCIUM PHOSPHATE
Children's Oncology Group
Phase 3BB
Cixutumumab
National Cancer Institute (NCI)
Phase 2B
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 2B
Alisertib
Children's Oncology Group
Phase 2B

View all 12 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →